Synthego Corporation has been awarded a firm fixed price purchase order valued at twenty-six thousand three hundred thirty dollars by the National Institute of Dental and Craniofacial Research within the Department of Health and Human Services. Under this contract, Synthego will supply induced pluripotent stem cell clones to the agency as requested in a January 2024 presolicitation notice seeking "Knockin-Small, Cell Clone, iPSC, Synthego Supplied VIAL." Performance will occur at Synthego's Redwood City, California facilities through June 2024 to support the agency's biomedical research objectives. As the incumbent supplier for these specialized cell lines, Synthego is well positioned to further the National Institute of Dental and Craniofacial Research's mission to advance dental, oral, and craniofacial health.